Wiebke Sihver

8PUBLICATIONS
25CO-AUTHORS
Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsOrganometallic chemistryRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 19, 2025
It's a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies.

Johanna Trommer, Martin Ullrich, Falco Reissig

|Mar 26, 2025
Development of [99mTc]TcO-ABX474: Design, Synthesis, and Biological Evaluation of PSMA-Binding Technetium-99m Radioligands for SPECT Imaging of Prostate Cancer.

Christian Lis, Friedrich-Alexander Ludwig, Steffen Fischer

|Nov 20, 2024
Synthesis and Preclinical Evaluation of a Bispecific PSMA-617/RM2 Heterodimer Targeting Prostate Cancer.

Christos Liolios, Danai Bouziotis, Wiebke Sihver

|Aug 26, 2024
Cyclohexanediamine Triazole (CHDT) Functionalization Enables Labeling of Target Molecules with Al18F/68Ga/111In.

Wiebke Sihver, Martin Walther, Martin Ullrich

|Mar 27, 2019
Radiochemical and radiopharmacological characterization of a 64 Cu-labeled α-MSH analog conjugated with different chelators.

Feng Gao, Wiebke Sihver, Ralf Bergmann

|Jul 25, 2018
Exploring pitfalls of 64Cu-labeled EGFR-targeting peptide GE11 as a potential PET tracer.

Franziska Striese, Wiebke Sihver, Feng Gao

Pageof 2

Frequent Collaborators

3 joint publications

Jens Pietzsch

2 joint publications

Kristof Zarschler

1 joint publications

Martin Walther

1 joint publications

Robert Wodtke